Variations in Care and Real World Outcomes in those with Rectal Cancer: A protocol for the Ontario Rectal Cancer Cohort (OntaReCC) (Preprint)
Open Access
- 5 August 2022
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (8) , e38874
Abstract
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Individuals with rectal cancer require a number of pretreatment investigations, often require multidisciplinary treatment and require ongoing follow up after treatment is completed. Due to the complexity of treatments, large variations in practice patterns and outcomes have been identified. At present, few comprehensive population level datasets are available to assess interventions and outcomes in this group. The objective of the proposed study is to create a comprehensive database of individuals treated with rectal cancer in a single payer, universal health care system. This database will provide an excellent resource for investigators to study the variations in the delivery of care, and real world outcomes in this population. Objective: The objective of this study is to create a comprehensive database to allow for assessment of the delivery of care and outcomes in those with rectal cancer Methods: The Ontario Rectal Cancer Cohort (OntaReCC) database will include comprehensive details of the management and outcomes of those with rectal cancer, diagnosed in Ontario, Canada (population 14.6 million) between 2010 – 2019. Linked administrative datasets will be used to construct this comprehensive database. Individual and care provider characteristics, investigations, treatments, follow up and outcomes will be derived and linked. Surgical pathology details, including stage of disease, histopathology characteristics and quality of surgical excision, will be included. Ethics approval for this study was obtained through Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board. A number of research themes will initially be explored using the OntaRecc Database, including (i) the regional variability in the delivery of care and outcomes, (ii) predictors and impact of adherence to recommended care, and (iii) assessments of other understudied areas of rectal cancer care. Results: Approximately 20,000 individuals were identified who meet the inclusion criteria for this study. Data analysis is ongoing, with an expected completion date of March, 2023. This study was funded through the Canadian Institute of Health Research (CIHR) Operating Grant. Conclusions: The Ontario Rectal Cancer Cohort will include a comprehensive dataset of individuals with rectal cancer who received care within a single payer, universal health care system. This cohort will be used to determine factors associated with regional variability, adherence to recommended care and allow for an assessment of a number of understudies areas within the delivery of rectal cancer treatment.Keywords
This publication has 25 references indexed in Scilit:
- Lymph Node Evaluation for Colon Cancer in Routine Clinical Practice: A Population-Based StudyCurrent Oncology, 2017
- Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General PopulationClinical Oncology, 2017
- Utilization of pre‐operative imaging for colon cancer: A population‐based studyJournal of Surgical Oncology, 2016
- Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare DataJournal of Gastrointestinal Surgery, 2016
- Evaluating the effect of clinical care pathways on quality of cancer care: analysis of breast, colon and rectal cancer pathwaysJournal of Cancer Research and Clinical Oncology, 2016
- The effect of multidisciplinary teams for rectal cancer on delivery of care and patient outcome: has the use of multidisciplinary teams for rectal cancer affected the utilization of available resources, proportion of patients meeting the standard of care, and does this translate into changes in patient outcome?The American Journal of Surgery, 2016
- Management and Outcome of Colorectal Cancer Liver Metastases in Elderly PatientsJAMA Oncology, 2015
- Local Resection Compared With Radical Resection in the Treatment of T1N0M0 Rectal AdenocarcinomaDiseases of the Colon & Rectum, 2015
- Comparing national cancer registries: The National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) programJournal of Surgical Oncology, 2014
- An application of capture-recapture methods to the estimation of completeness of cancer registrationJournal of Clinical Epidemiology, 1988